Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06836440

Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults

The aim of this project is to explore whether vision correction can effectively slow cognitive decline in older adults.

The primary question it seeks to answer is: Can providing free near and/or distance vision correction glasses to older adults with refractive errors or uncorrected vision, who have normal baseline cognition and hearing, reduce the rate of cognitive decline over 36 months in a cost-effective manner? Researchers will compare the rate of cognitive decline over 36 months between older adults who receive refractive correction and those who do not.

Recruiting

Interested in participating?

Request Info

Key information

Age range

60 year–79 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Community health service centers

Ya'an, Sichuan, 610065, China

Location status: Recruiting

Location contact

Yuju Yingjing County Health Commission

CONTACT

[email protected]

0835-7623834

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Older adults who meet all of the following criteria will be eligible to participate in this study:
  • Registered as a rural resident (holding rural household registration);
  • Age from 60 to 79 years at the time of enumeration;
  • Resident in the household for > = 3 months and planning to reside in the local area for the trial duration;
  • Distance vision impairment (VI, presenting visual acuity [VA] < 6/12 in the better-seeing eye and improving to ≥ 6/7.5 or better in either eye with spectacle correction) and/or near VI (presenting near VA < 6/12 at 40 cm when measured binocularly and improving to ≥ 6/7.5 or better in either eye with near correction);
  • Independent mobility with or without the support of a walking stick;
  • Chinese version of the Mini-Mental State Examination (C-MMSE) score above the following cut-offs (out of 30): >17 for illiterate participants, >20 for those with primary school education, >22 for those with junior high school education, and >23 for those with high school education or above.
  • Willingness to participate, to be randomized to either study group, and to adhere to the protocol

Exclusion criteria

  • Presence of glaucoma or visually significant cataract, or a history of surgical treatment for these or other major ocular conditions;
  • Consistent use of prescription spectacles and/or hearing aids;
  • Serious medical illness likely to result in loss to follow-up. Those less severely affected by conditions such as hypertension and/or diabetes will be eligible;
  • Failure on the whispered voice hearing screening test in the better ear (unable to repeat > = 3 out of 6 words whispered from behind the participant at a distance of 50 cm);

Treatment and study plan

Free Prescription Glasses

Device

Participants can choose from a variety of frames, and the research team will customize the glasses according to their pupillary distance and prescription. Once the glasses are ready, they will be provided to the participants following standard usage instructions. In case of loss or damage, participants should report it to the project team and will be provided with replacement glasses as needed. Each year, participants in the intervention group will undergo an eye exam to assess changes in vision, and their glasses prescription will be updated if necessary.

Primary outcomes

  1. **Chinese version of the Global Cognitive Score Scale**

    Time frame: Each participant will undergo cognitive assessments at baseline, 12 months, 24 months, and 36 months to evaluate the impact of the intervention on cognitive decline.

    The primary endpoint is the change in cognitive function over three years, which is comprehensively determined using the Chinese version of the Global Cognitive Score Scale-by administering the Chinese version Mini-Mental State Examination (C-MMSE), Beijing version of the Montreal Cognitive Assessment (MoCA), Telephone Interview for Cognitive Status (TICS), Community Screening Instrument for Dementia Interviewee Part (CSI-D), and Number Series Test.

Study contacts

Contact information is provided by the study sponsor or research team.

Yuju Wu

CONTACT

[email protected]

86+18382096899

Sponsors and collaborators

Lead sponsor

Yuju Wu

Other

Registry information

Official study title

The Impact of Spectacle Intervention for Refractive Error and Presbyopia on Cognitive Function in Rural Older Adults

Acronym: CLEVER

Important dates

Study start
2025
Primary completion
2028
Study completion
2030
First posted
Feb 20, 2025
Registry last updated
May 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.